Economic evaluation of varicella vaccination in Spain: results from a dynamic model (Q79965616)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Economic evaluation of varicella vaccination in Spain: results from a dynamic model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Lenne X

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Gil A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ridao M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Lluch JA

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Dervaux B

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

4 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

47-48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

6980-6989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

The epidemiology of varicella and its complications.

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Community impact of childhood varicella infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Epidemiology of severe varicella-zoster virus infection in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

The burden of severe varicella in Spain, 1995--2000 period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Varicella mortality: trends before vaccine licensure in the United States, 1970-1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Live vaccine used to prevent the spread of varicella in children in hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

The cost-effectiveness of routine childhood varicella vaccination in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Costs And Benefits Of Routine Varicella Vaccination In German Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

An economic analysis of varicella vaccination for health care workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Varicella and paediatric staff: current practice and vaccine cost-effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

An economic evaluation of varicella vaccination in Italian adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Varicella vaccination in Italy : an economic evaluation of different scenarios

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

The economic value of childhood varicella vaccination in France and Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

The cost-effectiveness of varicella vaccination in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Varicella vaccination in England and Wales: cost-utility analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Instituting a routine varicella vaccination program in Canada: an economic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

The cost-effectiveness of varicella vaccine programs for Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Childhood vaccination against chickenpox: an analysis of benefits and costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

A cost-benefit analysis of a routine varicella vaccination program for United States Air Force Academy cadets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

A cost benefit analysis of routine varicella vaccination in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

The estimation of age-related rates of infection from case notifications and serological data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Comparing hospital discharge records with death certificates: can the differences be explained?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Accuracy of death certificate completion: the need for formalized physician training

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Modelling the impact of immunization on the epidemiology of varicella zoster virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

The postmarketing safety profile of varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Postmarketing evaluation of the safety and effectiveness of varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Modified varicella-like syndrome in children previously vaccinated with live attenuated measles, mumps, rubella and varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Modified varicella-like syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Varicella vaccine safety, incidence of breakthrough, and factors associated with breakthrough in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Economic evaluations of varicella vaccination programmes: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Economic evaluation of vaccination programs: the impact of herd-immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Effects of varicella vaccination on herpes zoster incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

Incidence of Herpes Zoster, Before and After Varicella‐Vaccination–Associated Decreases in the Incidence of Varicella, 1992–2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.051

10.1016/J.VACCINE.2006.04.051

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860909%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference